GHK-Cu (copper peptide): what the research actually says
GHK-Cu (glycyl-histidyl-lysine bound to copper) is unusual on this site because it's genuinely two different products wearing one name: a topical skincare ingredient with actual supporting research, and an injectable "wellness" peptide with almost none. Conflating the two is where the misleading marketing happens.
What GHK-Cu is
GHK-Cu is a small peptide that binds copper and occurs naturally in the body, where levels decline with age. It has been studied for decades for a role in wound healing, collagen production, and tissue remodeling.2 That underlying biology is why it ended up in both cosmetic labs and injectable "research use only" catalogs, following two very different regulatory paths from there.
The topical evidence: the stronger of the two cases
Topical GHK-Cu is an active area of published research. Recent studies have examined its delivery through the skin using liposome and nanocarrier formulations, and its use in antioxidant, anti-inflammatory, and wound-healing skin applications.2 Harvard Health Publishing notes that "some evidence suggests that some peptides in eye creams that stimulate collagen could possibly help skin appear more youthful" — a cautious but real statement of supporting evidence, not a guarantee.
Because it's applied topically as a cosmetic ingredient rather than injected, GHK-Cu skincare products fall under a different, lighter regulatory bar: the FDA regulates cosmetics but does not "approve" them before they reach the market the way it does drugs. That's a meaningfully different, and lower, bar than an approved medication clears, but it also means the topical case for GHK-Cu isn't the same unregulated void that injectable wellness peptides sit in.
The injectable version: a different, weaker case
Injectable or subcutaneous GHK-Cu, marketed for broader anti-aging, hair, or general wellness claims, is a separate product with a separate evidence problem. It is not an FDA-approved drug, has essentially no published controlled human trials at injectable doses, and is typically sold through the same "research use only" channel as other unapproved peptides. Injecting anything introduces sterility, dosing, and systemic-absorption risks that a topical cream never has to answer for, which makes the evidence gap here matter more, not less.
| Route | Evidence picture | Regulatory picture |
|---|---|---|
| Topical (skincare) | Real published research on delivery and skin effects | FDA-regulated as a cosmetic; no premarket drug approval required |
| Injectable (wellness) | Essentially no published human trials | Not FDA-approved; sold outside regulated drug manufacturing |
"When you're talking about peptides being promoted online, those health claims have not been vetted by any expert group, the FDA, or anyone else. The health claims are divorced from data."
— Dr. Pieter Cohen, Associate Professor of Medicine, Harvard Medical School, in Harvard Health Publishing (July 2026)
What's actually known about safety
Topical GHK-Cu products are widely available cosmetic ingredients with a long track record of use on skin. Injectable GHK-Cu carries the same open questions as other unapproved injectable peptides: no established human dosing, no long-term safety data, and no verification of what's actually in a "research use only" vial. Those are separate risk profiles, and it's worth knowing which one a specific product actually is before treating any claim about "GHK-Cu" as settled.
If you're considering it
For skin goals, a dermatologist can advise on evidence-backed topical options. For anything injectable, the same rule applies as elsewhere on this site: a licensed clinician, not a research-chemical vendor, is the only channel with any quality control. See our safest way to try peptides guide.
Sources
- U.S. Food & Drug Administration — "FDA Authority Over Cosmetics: How Cosmetics Are Not FDA-Approved, but Are FDA-Regulated."
- Peer-reviewed literature on topical GHK-Cu — Molecules (2025), skin permeation of liposome-encapsulated GHK-Cu; Materials Today Bio (2026), copper peptide in infected wound healing.
- Harvard Health Publishing — "Peptides: what they are, potential benefits, and safety concerns."